1. Alotec
2. Alupent
3. Astmopent
4. Metaprel
5. Metaproterenol
6. Metaproterenol Polistirex
7. Orciprenaline
8. Orciprenaline Sulfate
9. Polistirex, Metaproterenol
1. Orciprenaline Sulfate
2. 5874-97-5
3. Metaproterenol Hemisulfate
4. Metaproterenol Hemisulfate Salt
5. Metaproterenol Sulphate
6. Orciprenaline Sulphate
7. Alupent
8. Prometa
9. Orciprenaline (hemisulfate)
10. Metaproterenol (hemisulfate)
11. Th-152
12. Metaproterenol Sulfate, Orciprenaline Sulfate
13. 5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol;sulfuric Acid
14. Dsstox_cid_25391
15. Dsstox_rid_80848
16. Dsstox_gsid_45391
17. Gj20h50yf0
18. Metaproterenol Sulfate [usan]
19. Prestwick_845
20. Alupent (tn)
21. Ncgc00016662-01
22. Cas-5874-97-5
23. Schembl41815
24. Metaproterenol Sulfate (usp)
25. Orciprenaline Sulfate (jp17)
26. Chembl1568057
27. Dtxsid4045391
28. Hms1569f11
29. Hms2096f11
30. Hms3262c10
31. Hms3713f11
32. Metaproterenol Sulfate [mi]
33. Orciprenaline Sulfate [jan]
34. Bcp13601
35. Orciprenaline For System Suitability
36. Tox21_110551
37. Tox21_500734
38. Metaproterenol Sulfate [vandf]
39. Orciprenaline Sulfate [mart.]
40. Akos015994757
41. Orciprenaline Sulfate [who-dd]
42. Tox21_110551_1
43. Ccg-220505
44. Ccg-222038
45. Lp00734
46. Metaproterenol Sulfate [usp-rs]
47. Ss-4263
48. Ncgc00015655-09
49. Ncgc00094078-01
50. Ncgc00261419-01
51. Db-053257
52. Metaproterenol Sulfate [orange Book]
53. Orciprenaline Sulfate [ep Monograph]
54. Eu-0100734
55. Ft-0628263
56. Sw198971-2
57. En300-50867
58. Metaproterenol Sulfate [usp Monograph]
59. D00685
60. M 2398
61. 874m975
62. Metaproterenol Sulfate;th-152; Th 152; Th152
63. Sr-01000872665
64. Sr-01000872665-1
65. Metaproterenol Hemisulfate 100 Microg/ml In Methanol
66. Q27279120
67. Z955123630
68. 5-(1-hydroxy-2-(isopropylamino)ethyl)benzene-1,3-diol Hemisulfate
69. Bis(5-(1-hydroxy-2-(isopropylamino)ethyl)benzene-1,3-diol) Sulfate
70. Metaproterenol Sulfate, United States Pharmacopeia (usp) Reference Standard
71. Orciprenaline Sulfate, European Pharmacopoeia (ep) Reference Standard
72. (+/-)-3,5-dihydroxy-.alpha.-((isopropylamino)methyl)benzyl Alcohol Sulfate (2:1)
73. (+/-)-3,5-dihydroxy-.alpha.-((isopropylamino)methyl)benzyl Alcohol Sulphate (2:1)
74. Bis(5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol); Sulfuric Acid
75. Orciprenaline For System Suitability, European Pharmacopoeia (ep) Reference Standard
76. 1,3-benzenediol, 5-(1-hydroxy-2-(1-methylethyl)amino)ethyl-, (+/-)-, Sulfate (2:1) (salt)
77. 1,3-benzenediol, 5-(1-hydroxy-2-(1-methylethyl)amino)ethyl-, (+/-)-, Sulphate (2:1) (salt)
Molecular Weight | 520.6 g/mol |
---|---|
Molecular Formula | C22H36N2O10S |
Hydrogen Bond Donor Count | 10 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 8 |
Exact Mass | 520.20906652 g/mol |
Monoisotopic Mass | 520.20906652 g/mol |
Topological Polar Surface Area | 228 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 258 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Metaproterenol sulfate |
Drug Label | Metaproterenol sulfate syrup is an oral bronchodilator. Each teaspoonful (5 mL), for oral administration, contains metaproterenol sulfate 10 mg. In addition, each teaspoonful (5 mL) contains the following inactive ingredients:citric acid, edetate dis... |
Active Ingredient | Metaproterenol sulfate |
Dosage Form | Tablet; Syrup; Solution |
Route | Oral; Inhalation |
Strength | 10mg/5ml; 0.4%; 0.6%; 10mg; 20mg |
Market Status | Prescription |
Company | Wockhardt; Silarx; Mylan Speclt; Par Pharm |
2 of 2 | |
---|---|
Drug Name | Metaproterenol sulfate |
Drug Label | Metaproterenol sulfate syrup is an oral bronchodilator. Each teaspoonful (5 mL), for oral administration, contains metaproterenol sulfate 10 mg. In addition, each teaspoonful (5 mL) contains the following inactive ingredients:citric acid, edetate dis... |
Active Ingredient | Metaproterenol sulfate |
Dosage Form | Tablet; Syrup; Solution |
Route | Oral; Inhalation |
Strength | 10mg/5ml; 0.4%; 0.6%; 10mg; 20mg |
Market Status | Prescription |
Company | Wockhardt; Silarx; Mylan Speclt; Par Pharm |
Tocolytic Agents
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
LOOKING FOR A SUPPLIER?